Emergency treatment after accidentally taking ibrutinib/ibrutinib

Ibrutinib/Ibrutinib (Ibrutinib) is an innovative targeted anti-cancer drug jointly developed by Johnson Johnson and Pharmacyclics. It was approved by the U.S. Food and Drug Administration (FDA) in 2013 and is marketed under the trade name Imbruvica. This drug is mainly used to treat a variety of B-cell malignant tumors, such as mantle cell lymphoma, chronic lymphocytic leukemia, etc., with good efficacy.

The mechanism of action of ibrutinib is as a small molecule BTK inhibitor, which can effectively inhibit the proliferation and survival of malignant B cells and block their migration and adhesion. However, behind this powerful medicinal effect, there are also certain side effects and risks hidden.

When you accidentally take ibrutinib, you should seek medical assistance immediately and explain the accident to your doctor in detail so that you can receive professional medical advice. Possible side effects of ibrutinib include bleeding, increased risk of infection, decreased blood cell counts, interstitial lung disease, cardiac arrhythmias, hypertension, and secondary malignancies. Therefore, a variety of uncomfortable symptoms may occur in the body after ingestion.

After the doctor understands the situation, he will take appropriate treatment measures based on the patient's actual condition. These measures may include inducing vomiting, gastric lavage, or administering specific antidotes to minimize the potential harm of the drug to the body. In pregnant women, ibrutinib may have adverse effects on the fetus. Therefore, if you accidentally take it, you should seek medical treatment immediately and undergo relevant examination and consultation.

In addition, ibrutinib may cause bone and muscle pain, joint pain and other problems. Therefore, you should pay attention to your body's reaction after accidentally taking it, and report any abnormal symptoms to your doctor in time.